Role of T cells in drug allergies

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 53, Issue 3, 1998, Pages 225-232

  Pichler, W J ^a   Schnyder, B ^a   Zanni, M P ^a   Hari, Y ^a   Von Greyerz, S ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ACYLTRANSFERASE; CD8 ANTIGEN; CYCLOSPORIN A; CYTOKINE; IMMUNOGLOBULIN E; INTERLEUKIN 4; INTERLEUKIN 5; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PENICILLAMINE; PENICILLIN DERIVATIVE; PROCAINAMIDE; SULFAMETHOXAZOLE; SULFONAMIDE; SUPERANTIGEN; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN;

AUTOIMMUNITY; CONTACT DERMATITIS; CROSS REACTION; DRUG HYPERSENSITIVITY; DRUG METABOLISM; EOSINOPHILIA; HEPATITIS; HUMAN; IMMUNOGENICITY; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; RASH; REVIEW; T LYMPHOCYTE; VIRUS INFECTION;

EID: 0031881954     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1398-9995.1998.tb03881.x     Document Type: Review

References (64)

1. Hoigné R, Schlumberger HU, Vervloet D. Zoppi M. Epidemiology of allergic reactions. In: Burr M, editor. Epidemiology of clinical allergy. Epidemiology of allergic reactions to drugs. Monographs in Allergy, vol. 31. Basel: Karger, 1993:140-70.
2. Bayard PJ, Berger TG, Jacohson MA. Drug hypersensitivity reactions and human immunodeficiency virus disease. J Acquir Immune Defic Syndr 1992;5:1237-57.
3. Geyman JP, Erickson S. The ampicillin rash as a diagnostic and management problem: case report and literature review. J Fam Pract 1978;7:493-6.
4. Blanca M, Vega JM, Garcia J, Miranda A, Carmona MJ, Juarez C. New aspects of allergic reactions to betalactams: crossreactions and unique specificities. Clin Exp Allergy 1994;24:407-15.
5. Gell PG, Coombs RR, editors. The classification of allergic reactions underlying disease. In: Clinical aspects of immunology. Oxford: Blackwell Scientific, 1963.
6. Katz DH, Benacerraf B. The regulatory influence of activated T cells and B cell responses to antigen. Adv Immunol 1972;15:1-94.
7. Eisen HN, Orris L, Belman S. Elicitation of delayed allergic skin reactions to haptens: the dependence of elicitation on hapten combination with proteins. J Exp Med 1952;95: 473-81.
8. Carr A, Swanson C, Penny R, Cooper DA. Clinical and laboratory markers of hypersensitivity to trimethoprimsulfamethoxazole in patients with Pneumocystis carinii pneumonia and AIDS. J Infect Dis 1993;167:180-5.
9. Porcelli SA, Morita CT, Modlin RL. T-cell recognition of non-peptide antigens. Curr Opin Immunol 1996;8:510-16.
10. Morita CT, Beckman EM, Bukowski JF, et al. Direct presentation of nonpeptide prenyl pyrophosphate antigens to human γδ T cells. Immunity 1995;3:495-507.
11. Beckman EM, Porcelli SA, Morita CT, Behar SM, Furlong ST, Brenner MB. Recognition of a lipid antigen by CD1-restricted αβ+ T cells. Nature 1994;372:691-4.
12. Tanaka Y, Morita CT, Tanaka Y, Nieves E, Brenner MB, Bloom BR. Nature and synthetic non-peptide antigens recognized by human γδ T cells. Nature 1995;375:155-8.
13. Martin S, Weltzien HU. T cell recognition of haptens: a molecular view. Int Arch Allergy Immunol 1994; 104: 10-16.
14. Weltzien HU, Moulon C, Martin S, Padovan E, Hartmann U, Kohler J. T cell immune response to haptens: structural models for allergic and autoimmune reactions. Toxicology 1996;107:141-51.
15. Ortmann B, Martin S, von Bohin A, Schlitz E, Hoschutzky H, Weltzien HU. Synthetic peptides anchor T-cell specific TNP epitopes to MHC antigens. J Immunol 1992;148:1445-50.
16. Köhler J, Hartmann U Grimm R, Pflugfelder U. Weltzien HU. Carrier-independent hapten recognition and promiscuous MHC restriction by CD4+ T cells induced by trinitrophenylated peptides. J Immunol 1997;158:591-7.
17. Batchelor FR, Janet MD, Gazzard DK. Penicillin allergy: the formation of the penicilloyl determinant. Nature 1965;206:362-4.
18. Sullivan TJ. Drug allergy. In: Middleton E, Reed CE, Ellis EF, Adkinson NF, Yunginger JW, Busse WW, editors. Allergy: principles and practice. St Louis, MO: Mosby Year Book, 1993:1726-46.
19. Levine BB. Immunochemical mechanisms involved in penicillin hypersensitivity in experimental animals and in human beings. Fed Proc 1965;24:45-50.
20. Parker CW. Immunochemical mechanisms in penicillin allergy. Fed Proc 1965;24:51-6.
21. de Weck AL, Schneider CW, Gutersohn J. The role of penicilloylated protein impurities, penicillin polymers and dimers in penicillin allergy. Int Arch Allergy Appl Immunol 1968;33:535-42.
22. Park BK, Coleman JW, Kitteringham NR. Drug disposition and drug hypersensitivity. Biochem Pharmacol 1987;36:581-60.
23. Levine BB, Redmond AP. Minor haptenic determinant-specific reagents of penicillin hypersensitivity in man. Int Arch Allergy Appl Immunol 1969;35:445-9.
24. Koponen M, Pichler WJ, de Weck AL. T cell reactivity to penicillin: phenotypic analysis of in vitro activated cell subsets. J Allergy Clin Immunol 1986;78:645-52.
25. Brander C, Mauri-Hellweg D, Bettens F, Rolli H, Goldman M, Pichier WJ. Heterogeneous T cell responses to β-lactam-modified self structures are observed in penicillin allergic individuals. J Immunol 1995;155:2670-8.
26. Padovan E, Mauri-Hellweg D, Pichler WJ, Weltzien HU. T cell recognition of penicillin G: structural features determining antigenic specificity. Eur J Immunol 1996; 26:42-8.
27. Mauri-Hellweg D, Zanni MP, Frei E, et al. Cross-reactivity Of T cell lines and clones to β-lactam antibiotics. J Immunol 1996;157:1071-9.
28. Padovan E, Bauer T, Tongio MM, Kalbacher H. Weltzien HU. Penicilloyl peptides are recognized as T cell antigenic determinants in penicillin allergy. Eur J Immunol 1997;27: 1303-7.
29. Cribb AE, Spielberg SS. Sulfamethoxazole is metabolized to the hydroxylamine in humans. Clin Pharmacol Ther 1993;51:522-6.
30. Leeder JS, Dosch HM, Spielberg SS. Cellular toxicity of sulfamethoxazole reactive metabolites. Biochem Pharmacol 1990;41:567-73.
31. Grant DM, Morike K, Eichelbaum M, Meyer UA. Acetylation pharmacokinetics. The slow acetylator phenotype is caused by decreased or absent arylamine N-acetyltransferase in human liver. J Clin Invest 1990;85:968-72.
32. Rieder MJ, Shear NH, Kanee A. Tang BK, Spielberg SP Prominence of slow acetylator phenotype among patients with sulfonamide hypersensitivity reactions. Clin Pharmacol Ther 1991;49:13-17.
33. Cribb AE, Nakamura H, Grant DM, Miller MA. Spielberg SP. Role of polymorphic and monomorphic human arylamine N-acetyltransferase in determining sulfamethoxazole metabolism. Biochem Pharmacol 1993;45:1277-88.
34. Crispe IN, Mehal WZ. Strange brew: T cells in the liver. Immunol Today 1996;17:522-5.
35. Huang Lin, Soldevila G, Leeker M, Flavell R, Crispe IN. The liver eliminates T cells undergoing antigen-triggered apoptosis in vivo. Immunity 1994;1:741-9.
36. Schnyder B, Mauri-Hellweg D, Zanni MP, Bettens F, Pichler WJ. Direct, MHC dependent presentation of the drug sulfamethoxazole to human αβ T cell clones. J Clin Invest 1997;100:136-40.
37. Zanni MR von Greyerz S, Schnyder B, Vallitutti S, Pichler WJ, Rapid, HLA restricted, processing and metabolism independent recognition of drugs by human αβ+ T lymphocytes. J Immunol (submitted).
38. Rhodes J, Chen H, Hall SR, et al. Therapeutic potentiation of the immune system by costimulatory Schiff-base-forming drugs. Nature 1995;376:16-17.
39. Achari A, Somers DO, Chapness JN, Bryant PK. Rosemund J, Stammers DK. Crystal structure of the antibacterial sulfonamide drug target dihydropteroale synthase. Nature Struc Biol 1997;4:490-7.
40. Romagnoli P, Spinas GA, Sinigaglia F. Gold-specific T cells in rheumatoid arthritis patients treated with gold. J Clin Invest 1992;89:254-8.
41. Romagnoli PA, Labhardt M, Sinigaglia F. Selective interaction of Ni with an MHC-bound peptide. EMBO J 1991;10:1303-6.
42. Riley RJ, Leeder JS. In vitro analysis of metabolic predisposition to drug hypersensitivity reactions. Clin Exp Immunol 1995;99:1-6.
43. Jiang X, Khursigara G, Rubin RL. Transformation of lupus-inducing drugs to cytotoxic products by activated neutrophils. Science 1995;266:810-13.
44. Vittorio CC, Muglia JJ. Anticonvulsant hypersensitivity syndrome. Arch Intern Med 1995;155:2285-9.
45. De Vriese AS, Philippe J, van Renterghem DM, et al. Carbamazepine hypersensitivity syndrome: report of 4 cases and review of the literature. Medicine (Baltimore) 1995;74:144-51.
46. van der Ven AJ, Koopmans PP, Vree TB, et al. Adverse reactions to co-trimoxazole in HIV infections. Lancet 1991;338:431-3.
47. Pichler WJ. Medikamentenallergie. In: Peter HH, Pichler WJ, editors. Klinische Immunologie. München: Urban & Schwarzenberg, 1996;718-35.
48. Schnyder B, Frütig K, Mauri-Hellweg D, et al. T cell mediated cytotoxicity in sulfamethoxazole induced skin reactions. J Clin Invest (submitted).
49. Mauri-Hellweg, D, Bettens F, Mauri D, Brander C, Hunziker T, Pichler WJ. Activation of drug-specific CD4+ and CD8+ T cells in individuals allergic to sulfamethoxazole, phenytoin and carbamazepine. J Immunol 1995;155:462-72.
50. Zanni MP, Mauri-Hellweg D, Brander C, et al. Characterization of lidocaine specific T cells. J Immunol 1997;158: 1139-48.
51. Hertl M, Jugert F, Merk HF. CD8+ dermal T cells from a sulfamethoxazole-induced bullous exanthem proliferate in response to drug-modified liver microsomes. Br J Dermatol 1995; 132:215-20.
52. Zanni MP, von Greyerz S, Schnyder B, Wendland T, Pichler WJ. Drug recognition by specific αβ+ T cell clones in association of multiple HLA-DR alleles. Immunol Int (submitted).
53. Pantaleo G, Demarest JF, Soudeyns H, et al. Major expansion of CDH+ T cells with a predominant Vβ usage during the primary immune response to HIV. Nature 1994;370: 463-7.
54. Pichler WJ, Mauri-Hellweg D, Baumann K, Bettens F. Selective expression of T cell receptor Vβ in acute infectious mononucleosis. Arch Int Med 1995;55:1555-6.
55. Moulon C, Vollmer J, Weltzien HU. Characterization of processing requirements and metal cross-reactivities in T cell clones from patients with allergic contact dermatitis to nickel. Eur J Immunol 1995;25:3308-15.
56. Vollmer J, Fritz M, Doromy A, Weltzien HU, Moulon C. Dominance of the BV17 element in nickel specific human T cell receptors relates to severity of contact sensitivity. Eur J Immunol 1997;27:1865-74.
57. Pichler WJ, Zanni M, von Greyerz S, Schnyder B, Mauri-Helhveg D, Wendland T, High IL-5 production by drug specific T cell clones. Int Arch Appl Allergy Immunol 1997;113:177-80.
58. Dent LA, Strath M, Mellor AL, Anderson CJ. Eosinophilia in transgenic mice expressing interleukin 5. J Exp Med 1990;172:1425-31.
59. Merk HF, Hertl M. Immunologic mechanisms of cutaneous drug reactions. Semin Cutan Med Surg 1996;15:228-35.
60. Hertl M, Bohlen H, Jugert F, Merk HF. Predominance of epidermal CD8+ T lymphocytes in bullous cutaneous reactions caused by β-lactam antibiotics. J Invest Dermatol 1993,101:794-9.
61. Herman A, Labrecque N, Thibodeau J, Marrack P, Kappler JW, Sekaly RP. Identification of the staphylococcal enterotoxin A superantigen binding site in the β1 domain of the human histocompatibility antigen HLA-DR. Proc Natl Acad Sci U S A 1991;88:9954-8.
62. Kappler J, Kotzian B, Herron L, et al. Vβ-specific stimulation of human T cells by staphylococcal toxins. Science 1989;244:811-13.
63. Miranda A, Blanca M, Vega JM, et al. Cross-reactivity between a penicillin and a cephalosporin with the same side chain. J Allergy Clin Immunol 1996;98:671-7.
64. Zanni MP, von Greyerz S, Schnyder B, Hari Y, Frei E, Pichler WJ. T cell reactivity to local anesthetics: in vivo and in vitro crossreactivily and identification of a possible core structure for T cell recognition. J Clin Invest (submitted).